A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib

Lee, J. Y.; Sun, J.-M.; Lim, S. H.; Kim, H.; Yoo, K. H.; Jung, K. S.; Song, H.-N.; Ku, B. M.; Koh, J.; Bae, Y.-H.; Lee, S.-H.; Ahn, J. S.; Park, K.; Ahn, M.-J.

期刊名称Clinical Cancer Research
作者Lee, J. Y.; Sun, J.-M.; Lim, S. H.; Kim, H.; Yoo, K. H.; Jung, K. S.; Song, H.-N.; Ku, B. M.; Koh, J.; Bae, Y.-H.; Lee, S.-H.; Ahn, J. S.; Park, K.; Ahn, M.-J.
印刷ISSN1078-0432
电子ISSN1557-3265
文件大小4264.04KB
发表时间2015-12-14
DOI10.1158/1078-0432.CCR-15-1653

发现好书期刊，享受阅读乐趣

A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib